Henry Schein (NASDAQ:HSIC) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Henry Schein (NASDAQ:HSIC) had its target price boosted by research analysts at Wells Fargo & Company from $70.00 to $76.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price would indicate a potential upside of 6.32% from the company’s current price.

HSIC has been the subject of a number of other research reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Henry Schein in a report on Friday, October 31st. Wall Street Zen lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. JPMorgan Chase & Co. reduced their target price on Henry Schein from $80.00 to $76.00 and set an “overweight” rating for the company in a research note on Thursday, August 7th. Barrington Research reissued an “outperform” rating and issued a $78.00 price objective on shares of Henry Schein in a research note on Wednesday, October 22nd. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Five investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $77.33.

Henry Schein Price Performance

Shares of HSIC traded down $0.13 during trading hours on Wednesday, reaching $71.49. The stock had a trading volume of 320,280 shares, compared to its average volume of 1,716,495. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The stock has a market capitalization of $8.67 billion, a PE ratio of 23.07, a PEG ratio of 2.06 and a beta of 0.81. The company’s 50-day moving average is $66.17 and its two-hundred day moving average is $68.61.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. Research analysts expect that Henry Schein will post 4.74 EPS for the current year.

Hedge Funds Weigh In On Henry Schein

Several hedge funds have recently modified their holdings of the company. CYBER HORNET ETFs LLC bought a new position in shares of Henry Schein in the second quarter valued at approximately $25,000. MUFG Securities EMEA plc purchased a new position in Henry Schein in the second quarter worth $27,000. ANTIPODES PARTNERS Ltd bought a new position in Henry Schein in the 2nd quarter valued at $43,000. Steph & Co. purchased a new stake in shares of Henry Schein during the 2nd quarter valued at $44,000. Finally, CX Institutional increased its position in shares of Henry Schein by 107.3% during the 2nd quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after purchasing an additional 337 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.